Schrödinger, Inc. (SDGR) Stock Analysis & Investment Frameworks
Schrödinger, Inc. (SDGR) stock analysis on Invetso. Review Schrödinger, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Schrödinger, Inc. Company Overview
- Exchange: NASDAQ
- Sector: Technology
- Industry: Software - Application
- Country: US
Schrödinger, Inc. Key Financial Metrics
- Market Cap: $1.79B
- Revenue: $255.87M
- ROE: -16.37%
- ROIC: -31.77%
- Dividend Yield: N/A
About Schrödinger, Inc.
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Schrödinger, Inc. Investment Frameworks
Invetso analyzes Schrödinger, Inc. (SDGR) across the following frameworks:
- Schrödinger, Inc. 10Y Growth Potential
- Schrödinger, Inc. Scenario Analysis
- Schrödinger, Inc. Risks & Opportunities
- Schrödinger, Inc. Economic Moat
- Schrödinger, Inc. Business Model
- Schrödinger, Inc. Management
- Schrödinger, Inc. SWOT Analysis
- Schrödinger, Inc. Porter's 5 Forces
- Schrödinger, Inc. PESTLE Analysis
- Schrödinger, Inc. ESG Analysis